{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T04:34:30Z","timestamp":1780461270106,"version":"3.54.1"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>In 1817 and 1820, the German physician Justinus Kerner published a series of cases of lethal food poisoning that would unknowingly have a lasting impact on medical science. His compilation of over 75 cases linked the consumption of smoked sausages in the small town of Herrenberg in W\u00fcrttemberg, recounted a constellation of symptoms that today the authors call botulism. Now, over 2 centuries later, the discovery, study and refinement of the toxin causing clinical botulism has led to the acceptance of neuromodulators as a treatment for a wide variety of medical concerns.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVE<\/jats:title>\n            <jats:p>The aim of this article is to understand the many historical advances in the mechanism of action of botulinum neurotoxins, the wide range of indications that are currently available and <jats:italic toggle=\"yes\">Dermatologic Surgery<\/jats:italic>'s role in this evolution.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MATERIALS AND METHODS<\/jats:title>\n            <jats:p>A PubMed retrospective search to identify literature on the history of botulinum toxin was undertaken.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>Botulinum toxin is the newest therapeutic generational drug with over 30 approved indications in 90 countries. There are now 7 FDA (food and drug administration) approved neuromodulators with several more under current review. <jats:bold>CONCLUSION<\/jats:bold>\n                                 <jats:italic toggle=\"yes\">Dermatologic Surgery<\/jats:italic> has had a seminal role in the advancement of neuromodulators and publishing associated literature.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dss.0000000000004567","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T13:01:18Z","timestamp":1739538078000},"page":"347-352","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["The History of Neuromodulators in Dermatologic Surgery"],"prefix":"10.1097","volume":"51","author":[{"given":"Andrea","family":"Cespedes Zablah","sequence":"first","affiliation":[{"name":"University of Illinois, Chicago School of Medicine, Chicago, Illinois;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth L.","family":"Matarasso","sequence":"additional","affiliation":[{"name":"Clinical Professor of Dermatology, University of California School of Medicine, SF, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Carruthers","sequence":"additional","affiliation":[{"name":"Clinical Professor of Ophthalmology, University of British Columbia School of Medicine, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"issue":"Suppl 8","key":"R1-20250328","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1002\/mds.20003","article-title":"Historical notes on botulism, Clostridium botulinum, botulinum toxin, and the idea of the therapeutic use of the toxin","volume":"19","author":"Erbguth","year":"2004","journal-title":"Mov Disord"},{"key":"R3-20250328","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/bmj.316.7125.151c","article-title":"was named because of association with \u201csausage poisoning","volume":"316","author":"Torrens","year":"1998","journal-title":"BMJ"},{"key":"R4-20250328","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1076\/jhin.8.1.43.1774","article-title":"On the discovery of","volume":"8","author":"Devriese","year":"1999","journal-title":"Clostridium botulinum. J Hist Neurosci"},{"issue":"Suppl 1","key":"R5-20250328","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1093\/asj\/sjw284","article-title":"AbobotulinumtoxinA: a 25-year history","volume":"37","author":"Monheit","year":"2017","journal-title":"Aesthet Surg J"},{"key":"R6-20250328","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1097\/DSS.0000000000004284","article-title":"Botulinum toxin accessory proteins: are they just an accessory?","volume":"50","author":"Avelar","year":"2024","journal-title":"Dermatol Surg"},{"key":"R7-20250328","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1126\/science.130.3378.763","article-title":"The most poisonous poison","volume":"130","author":"Lamina","year":"1959","journal-title":"Science"},{"key":"R8-20250328","first-page":"924","article-title":"Pharmacologic weakening of extraocular muscles","volume":"12","author":"Scott","year":"1973","journal-title":"Invest Ophthalmol"},{"key":"R9-20250328","first-page":"734","article-title":"Botulinum toxin injection of eye muscles to correct strabismus","volume":"79","author":"Scott","year":"1981","journal-title":"Trans Am Ophthalmol Soc"},{"key":"R10-20250328","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1524-4725.1992.tb03295.x","article-title":"Treatment of glabellar frown lines with C. botulinum-A exotoxin","volume":"18","author":"Carruthers","year":"1992","journal-title":"J Dermatol Surg Oncol"},{"key":"R11-20250328","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3390\/toxins16060266","article-title":"Update on non-interchangeability of botulinum neurotoxin products","volume":"16","author":"Brin","year":"2024","journal-title":"Toxins (Basel)"},{"key":"R12-20250328","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1097\/DSS.0000000000004253","article-title":"RimabotulinumtoxinB: an update","volume":"50","author":"Song","year":"2024","journal-title":"Dermatol Surg"},{"key":"R13-20250328","first-page":"7","article-title":"Comparison of botulinum toxin types A and B: a bilateral and double-blind randomized evaluation in the treatment of canthal rhytides","volume":"29","author":"Matarasso","year":"2003","journal-title":"Dermatol Surg"},{"key":"R14-20250328","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/DSS.0000000000004282","article-title":"Optimizing neurotoxin selection","volume":"50","author":"Matarasso","year":"2024","journal-title":"Dermatol Surg"},{"key":"R15-20250328","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1097\/DSS.0000000000004346","article-title":"New and future developments in neurotoxins","volume":"50","author":"Yoelin","year":"2024","journal-title":"Dermatol Surg"},{"key":"R16-20250328","doi-asserted-by":"crossref","first-page":"3331024241278919","DOI":"10.1177\/03331024241278919","article-title":"Exploring the effects of extracranial injections of botulinum toxin type A on activation and sensitization of central trigeminovascular neurons by cortical spreading depression in male and female rats","volume":"44","author":"Melo-Carrillo","year":"2024","journal-title":"Cephalalgia"},{"key":"R17-20250328","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3390\/dj12060156","article-title":"Efficacy and safety of botulinum toxin in the management of temporomandibular symptoms associated with sleep bruxism: a systematic review","volume":"12","author":"Buzatu","year":"2024","journal-title":"Dent J (Basel)"},{"key":"R18-20250328","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3390\/toxins15060382","article-title":"Safety and effectiveness of repeated botulinum toxin A intracavernosal injections in men with erectile dysfunction unresponsive to approved pharmacological treatments: real-world observational data","volume":"15","author":"Giuliano","year":"2023","journal-title":"Toxins (Basel)"},{"key":"R19-20250328","doi-asserted-by":"crossref","first-page":"103893","DOI":"10.1016\/j.amjoto.2023.103893","article-title":"Comparing the Effects of Botulinum toxin-A and multiple surgical parasympathectomy on treatment of allergic rhinitis","volume":"44","author":"Ismail","year":"2023","journal-title":"Am J Otolaryngol"},{"key":"R20-20250328","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1097\/DSS.0000000000002807","article-title":"Phase I\/III clinical trial to evaluate the safety and efficacy of a new botulinum toxin (HU-014) versus OnabotulinumtoxinA in subjects with moderate-to-severe crow's feet lines","volume":"47","author":"Han","year":"2021","journal-title":"Dermatol Surg"},{"key":"R21-20250328","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1097\/DSS.0000000000002475","article-title":"Efficacy and safety of a novel botulinum toxin A for masseter reduction: a randomized, double-blind, placebo-controlled, optimal dose-finding study","volume":"47","author":"Hong","year":"2021","journal-title":"Dermatol Surg"},{"key":"R22-20250328","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1097\/DSS.0000000000002789","article-title":"Efficacy and safety of a new botulinum toxin (HU-014) versus existing onabotulinumtoxin A in subjects with moderate to severe glabellar lines","volume":"47","author":"Yoo","year":"2021","journal-title":"Dermatol Surg"},{"key":"R23-20250328","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1097\/DSS.0000000000003490","article-title":"Intradermal botulinum toxin A injection versus topical 2% glycopyrrolate for the treatment of primary facial hyperhidrosis: a pilot study and review of literature","volume":"48","author":"Nofal","year":"2022","journal-title":"Dermatol Surg"},{"key":"R24-20250328","doi-asserted-by":"crossref","first-page":"e174","DOI":"10.1097\/DSS.0000000000002943","article-title":"A study of botulinum toxin A for ultraviolet-induced hyperpigmentation: a randomized controlled trial","volume":"47","author":"Vachiramon","year":"2021","journal-title":"Dermatol Surg"},{"key":"R25-20250328","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1097\/DSS.0000000000004344","article-title":"Advances in topical botulinum therapy","volume":"50","author":"Edelson","year":"2024","journal-title":"Dermatol Surg"},{"key":"R26-20250328","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1097\/DSS.0000000000004359","article-title":"Neurotoxins and combination therapies","volume":"50","author":"Gawey","year":"2024","journal-title":"Dermatol Surg"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000004567","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T18:23:39Z","timestamp":1743359019000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000004567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000004567","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,14]]}}}